Literature DB >> 17921477

Risperidone versus olanzapine for treatment of schizophrenia.

Mahesh B Jayaram1, Prakash M Hosalli, Thomas S Stroup.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17921477      PMCID： PMC2779873          DOI： 10.1093/schbul/sbm101

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN： 0586-7614            Impact factor:   9.306


× No keyword cloud information.
  1 in total

Review 1.  Risperidone versus olanzapine for schizophrenia.

Authors:  M B Jayaram; P Hosalli; S Stroup
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19
  1 in total
  4 in total

Review 1.  Risperidone versus placebo for schizophrenia.

Authors:  Ranganath D Rattehalli; Sai Zhao; Bao Guo Li; Mahesh B Jayaram; Jun Xia; Stephanie Sampson
Journal:  Cochrane Database Syst Rev       Date:  2016-12-15

2.  Change in level of productivity in the treatment of schizophrenia with olanzapine or other antipsychotics.

Authors:  Hong Liu-Seifert; Haya Ascher-Svanum; Olawale Osuntokun; Kai Yu Jen; Juan Carlos Gomez
Journal:  BMC Psychiatry       Date:  2011-05-17       Impact factor: 3.630

3.  Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisons.

Authors:  Haya Ascher-Svanum; William S Montgomery; David P McDonnell; Kristina A Coleman; Peter D Feldman
Journal:  Int J Gen Med       Date:  2012-05-04

4.  Adherence and persistence to typical and atypical antipsychotics in the naturalistic treatment of patients with schizophrenia.

Authors:  Haya Ascher-Svanum; Baojin Zhu; Douglas E Faries; Jonathan P Lacro; Christian R Dolder; Xiaomei Peng
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.